Pharmacological Properties of Glutamatergic Drugs Targeting NMDA Receptors and their Application in Major Depression

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|10|1898-1922

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.10, 2013-03, pp. : 1898-1922

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting of NMDA Receptors in the Treatment of Major Depression

By  

Current Pharmaceutical Design, Vol. 20, Iss. 32, 2014-10 ,pp. : 5151-5159

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological Properties and Therapeutic Possibilities for Drugs Acting Upon Endocannabinoid Receptors

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 4, Iss. 6, 2005-12 ,pp. : 685-696

Bentham Science Publishers

Access to resources Recommend Favorite

Involvement of receptors in the modulation of the glutamatergic/NMDA neurotransmission in the dopaminergic systems

By Gronier B.   Debonnel G.  

European Journal of Pharmacology, Vol. 368, Iss. 2, 1999-03 ,pp. : 183-196

Elsevier

Access to resources Recommend Favorite

The drugs don’t work—or do they? Pharmacological and transgenic studies of the contribution of NMDA and GluR-A-containing AMPA receptors to hippocampal-dependent memory

By Bannerman D.   Rawlins J.   Good M.  

Psychopharmacology, Vol. 188, Iss. 4, 2006-11 ,pp. : 552-566

Springer Publishing Company

Access to resources Recommend Favorite

Targeting Brain Nicotinic Acetylcholine Receptors to Treat Major Depression and Co-Morbid Alcohol or Nicotine Addiction

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 5, 2015-06 ,pp. : 647-653

Bentham Science Publishers

Access to resources Recommend Favorite